The HYPERFlax trial for determining the anti-HYPERtensive effects of dietary flaxseed in newly diagnosed stage 1 hypertensive patients: Study protocol for a randomized, double-blinded, controlled clinical trial

Trials

Volumn 15, Issue 1, 2014, Pages

  Caligiuri, Stephanie P B ^a,b   Penner, Brian ^b   Pierce, Grant N ^a,b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Alpha linolenic acid; Blood pressure; Flaxseed; Hypertension; Nutrition

Indexed keywords

ANTIHYPERTENSIVE AGENT; LIPID; FAT INTAKE; LINOLENIC ACID;

ANTHROPOMETRY; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; BLOOD VESSEL TONE; CANADA; CHEMICAL ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LINSEED; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MOLECULE; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PHYSICAL ACTIVITY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; URINALYSIS; URINE; ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; EARLY DIAGNOSIS; FAT INTAKE; FLAX; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PLANT SEED; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-LINOLENIC ACID; BLOOD PRESSURE; DIETARY FATS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EARLY DIAGNOSIS; FEMALE; FLAX; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RESEARCH DESIGN; SEEDS; YOUNG ADULT;

EID: 84902301335     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-232     Document Type: Article

References (23)

1. World Health Organization A Global Brief on Hypertension: Silent killer, Global Public Health Crisis, WHO/DCO/WHD/2013 2013, Geneva, Switzerland: World Health Organization, 2, World Health Organization.
2. Bazzano LA, Green T, Harrison TN, Reynolds K. Dietary approaches to prevent hypertension. Curr Hypertens Rep 2013, 6:694-702.
3. Dupasquier CM, Weber AM, Ander BP, Rampersad PP, Steigerwald S, Wigle JT, Mitchell RW, Kroeger EA, Gilchrist JS, Moghadasian MM, Lukas A, Pierce GN. Effects of dietary flaxseed on vascular contractile function and atherosclerosis during prolonged hypercholesterolemia in rabbits. Am J Physiol Heart Circ Physiol 2006, 291:H2987-H2996.
4. Dupasquier CM, Dibrov E, Kneesh AL, Cheung PK, Lee KG, Alexander HK, Yeganeh BK, Moghadasian MH, Pierce GN. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am J Physiol Heart Circ Physiol 2007, 293:H2394-H2402.
5. Bassett CM, McCullough RS, Edel AL, Patenaude A, LaVallee RK, Pierce GN. The alpha-linolenic acid content of flaxseed can prevent the atherogenic effects of dietary trans fat. Am J Physiol Heart Circ Physiol 2011, 301:H2220-H2226.
6. Tomaz Pacheco J, Beltrame Daleprame J, Teles BG. Impact of dietary flaxseed (linum usitatissimum) supplementation on biochemical profile in healthy rats. Nutr Hosp 2011, 26:798-802.
7. Park JB, Velasquez MT. Potential effects of lignan-enriched flaxseed powder on bodyweight, visceral fat, lipid profile, and blood pressure in rats. Fitoterapia 2012, 83:941-946.
8. Rodriguez-Leyva D, Weighell W, Edel AL, Lavallee R, Dibrov E, Pinneker R, Maddaford TG, Ramjiawan B, Aliani M, Guzman R, Pierce GN. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension 2013, 62:1081-1089.
9. Hypertension Canada: The 2013 CHEP Recommendations. 2013, http://www.hypertension.ca/chep.
10. Aliani M, Ryland D, Pierce GN. Effect of flax addition on the flavor profile and acceptability of bagels. J Food Sci 2012, 77:S62-S70.
11. Aliani M, Ryland D, Pierce GN. Effect of flax addition on the flavor profile of muffins and snack bars. Food Res Int 2011, 44:2489.
12. DeFelice A, Willard J, Lawrence J, Hung J, Gordon MA, Karkowsky A, Targum S, Throckmorton DC, Girton J, Stertz B, Glasser SP, Lipicky RJ. The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis. J Hum Hypertens 2008, 22:659-668.
13. Raper N, Perloff B, Ingwersen L, Steinfeldt L, Jaswinder A. An overview of USDA's Dietary Intake Data System. J Food Comp Anal 2004, 17:545.
14. Kim Y, Park I, Kang M. Convergent validity of the international physical activity questionnaire (IPAQ): meta-analysis. Public Health Nutr 2013, 16:440-452.
15. Food and Drug Act GRAS Notice 000280: Whole and Milled Flaxseed 2009, Wangington, DC: US Food and Drug Administration, Food and Drug Act.
16. Shultz TD, Bonorden WR, Seaman WR. Effect of short-term flaxseed consumption on lignan and sex hormone metabolism in men. Nutr Res 1991, 11:1089-1100.
17. Frische EJ, Hutchins AM, Martini MC, Thomas W, Slavin JL. Effect of flaxseed and wheat bran on serum hormones and lignan excretion in premenopausal women. J Am Coll Nutr 2003, 22:550-554.
18. Faintuch J, Horie LM, Barbeiro HV, Barbeiro DF, Soriano FG, Ishida RK, Cecconello I. Systemic inflammation in morbidly obese subjects: response to oral supplementation with alpha-linolenic acid. Obes Surg 2007, 17:341-347.
19. Dodin S, Lemay A, Jacques H, Legare F, Forest JC, Masse B. The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial. J Clin Endocrinol Metab 2005, 90:1390-1397.
20. Bloedon LT, Balikai S, Chittams J, Cunnane SC, Berlin JA, Rader DJ, Szapary PO. Flaxseed and cardiovascular risk factors: results from a double blind, randomized, controlled clinical trial. J Am Coll Nutr 2008, 27:65-74.
21. Orcheson LJ, Rickard SE, Seidl MM, Thompson LU. Flaxseed and its mammalian lignan precursor cause a lengthening or cessation of estrous cycling in rats. Cancer Lett 1998, 125:69-76.
22. Chen J, Tan KP, Ward WE, Thompson LU. Exposure to flaxseed or its purified lignan during suckling inhibits chemically induced rat mammary tumorigenesis. Exp Biol Med (Maywood) 2003, 228:951-958.
23. Hemmings SJ, Barker L. The effects of dietary flaxseed on the Fischer 344 rat: I. development, behaviour, toxicity and the activity of liver gamma-glutamyltranspeptidase. Cell Biochem Funct 2004, 22:113-121.